ESP Block VS Intrathecal Opioid After Laparoscopic Colorectal Surgery

  • STATUS
    Recruiting
  • participants needed
    126
  • sponsor
    Indiana University
Send
Updated on 28 February 2022
See if I qualify

Summary

This study is being done to compare 2 types of pain control methods and determine which is more effective postoperatively for laparoscopic colorectal surgery. Group 1 will receive an intrathecal (IT) injection in the back in which a small dose duramorph and bupivacaine will be placed into the spinal fluid. Group 2 will receive an erector spinae plane (ESP) block in which bupivacaine and decadron are injected near the nerves under a muscle in the back.

Details
Condition Surgery
Age 18years - 80years
Treatment IT Injection, ESP Block
Clinical Study IdentifierNCT05257941
SponsorIndiana University
Last Modified on28 February 2022

Eligibility

 Yes No Not Sure

Inclusion Criteria

Patients undergoing an elective laparoscopic colorectal procedure at Indiana University Hospital or Methodist Hospital
ASA Class 1, 2, 3 (American Society of Anesthesiologists physical status classification system)
Age 18 to 80 years (male or female)
BMI < 40kg/m2
Desires regional anesthesia for postoperative pain control

Exclusion Criteria

Any contraindication for neuraxial analgesia or ESP block procedure
Contraindications for neuraxial analgesia include: Elevated intracranial pressure (except in cases of pseudo-tumor cerebri), infection at the site of injection, lack of consent from the patient, patient refusal, true allergy to any drug used in the spine, and uncorrected hypovolemia
Contraindications for ESP block procedure include: Infection at the site of injection, patient refusal, true allergy to any of the drugs used in the block, and lack of patient consent
Any patient undergoing a laparoscopic abdominoperineal resection
Any physical, mental or medical conditions which, in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery
Known true allergy to the study medications (morphine, bupivacaine, decadron, Tylenol, Celebrex)
Takes over 30 mg of oral morphine equivalents daily
Any history of substance abuse in the past 6 months
End stage liver disease, end stage renal disease
Body weight of < 50 kg
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.